GSPT1 Molecular Glue
FD-001: AML\MM\NHL
PIPELINE / 01
我们专注于降解癌症、病毒相关致病靶蛋白的 PRODED 小分子新药开发。
管线覆盖分子胶（Molecular Glue）、降解抗体偶联（DAC）与新型 E3 泛素连接酶等多种模式，涵盖肿瘤与非肿瘤治疗领域。
8个
在研项目
Pipeline programs
5个
肿瘤方向
Oncology
3个
非肿瘤方向
Non-Oncology
PROGRAMS / 02
| Targets / Modalities | Schedule (Compounds / Indications) | Rights | |||||
|---|---|---|---|---|---|---|---|
| Discovery | Optimization | IND Enabling | Phase 1 | Phase 2 | Phase 3 | ||
| Oncology 5 programs | |||||||
| GSPT1 Molecular Glue | Fendi Pharma | ||||||
| P53 activator Molecular Glue | Fendi Pharma | ||||||
| Undisclosed Molecular Glue | Fendi Pharma | ||||||
| HER2-DAC DAC | Fendi Pharma | ||||||
| CD33-DAC DAC | Fendi Pharma | ||||||
| Non-Oncology 3 programs | |||||||
| Undisclosed Molecular Glue | & | ||||||
| Undisclosed Molecular Glue | & | ||||||
| Undisclosed Novel E3 ligases | & | ||||||
进度条长度表示各项目当前所处的研发阶段；Rights 一栏标示相应项目的权益归属。管线信息将随研发进展持续更新。